US$ 20.04
trapezoid glp 1 glp-1 Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Agonist Response in Type 2 Diabetes and Atherosclerosis TrimRX | GLP-1 vs GIP:
Description
Those people, if they have a chronic condition that could potentially be helped by a GLP-1, are candidates for these drugs

In contrast, and consistent with data from mouse ventricular CMs, we observed that GLP-1(2836) failed to protect hESC-CMs from cytotoxicity under conditions of oxidative stress (Supplemental Figure 4C)

Higher maintenance doses required for optimal effect typically increase monthly expenditure
Beyond diet, lifestyle factors also matter

You don't have to figure that out alone
